Core Scientific director buys 6,000 shares at $16.33
A Core Scientific director bought additional shares in an open-market-type transaction and now directly holds over 265,000 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Core Scientific, Inc. (CORZ) director Eric Stanton Weiss purchased 6,000 shares of Common Stock on September 15, 2026, in a purchase classified as an open market or private transaction at $16.33 per share. Following this trade, he directly holds 265,262 shares of Core Scientific common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 6,000 | $16.33 | $98K |
Key Figures
Key Terms
Purchase in open market or private transaction financial
Rule 10b5-1 trading plan regulatory
direct ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CORZ report for director Eric Stanton Weiss?
Was the CORZ insider trade made under a Rule 10b5-1 trading plan?
Is the reported CORZ insider ownership direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.